NCT05730413

Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 122 (estimated)
• Sponsor: Cairo University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The goal of this interventional clinical trial is compare between two different dose regimens of bisoprolol (beta-blocker) in CABG patients in terms of efficacy and safety.

Conditions

• Coronary Artery Bypass Grafting
• Postoperative Atrial Fibrillation
• Coronary Artery Disease

Interventions

Type	Name	Description
DRUG	Bisoprolol	Bisoprolol dose was divided to be taken as 2.5 mg twice per day from hospital admission to discharge.
DRUG	Bisoprolol	Bisoprolol was taken as 5 mg per day from hospital admission till discharge.

Timeline

• Start date: 2021-08-25
• Primary completion: 2023-09-01
• Completion: 2023-09-01
• First posted: 2023-02-15
• Last updated: 2023-07-28

Locations

1 site across 1 country: Egypt